Exact Mass: 472.2613456
Exact Mass Matches: 472.2613456
Found 500 metabolites which its exact mass value is equals to given mass value 472.2613456
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Lucidenic acid K
Lucidenic acid K is found in mushrooms. Lucidenic acid K is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Lucidenic acid K is found in mushrooms. Lucidenic acid K is a triterpenoid.
Chenodeoxycholic acid sulfate
C24H40O7S (472.24946100000005)
The sulfate salt of Chenodeoxycholic acid is one of the 4 main organic acids produced by the liver. (Wikipedia). The sulfate salt of Chenodeoxycholic acid is one of the 4 main organic acids produced by the liver. [HMDB]
Chenodeoxycholic acid 3-sulfate
C24H40O7S (472.24946100000005)
Chenodeoxycholic acid 3-sulfate is produced by the action of enzymes existing in the microbial flora of the colonic environment. The major phase II metabolism of bile acids is sulfation mainly catalyzed by the hydroxysteroid sulfotransferase, forming the 3-sulfate conjugate. (PMID:16949895) [HMDB] Chenodeoxycholic acid 3-sulfate is produced by the action of enzymes existing in the microbial flora of the colonic environment. The major phase II metabolism of bile acids is sulfation mainly catalyzed by the hydroxysteroid sulfotransferase, forming the 3-sulfate conjugate. (PMID: 16949895). D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Ursodeoxycholic acid 3-sulfate
C24H40O7S (472.24946100000005)
Ursodeoxycholic acid is produced by the action of enzymes existing in the microbial flora of the colonic environment. The major phase II metabolism of bile acids is sulfation mainly catalyzed by the hydroxysteroid sulfotransferase, forming the 3-sulfate conjugate. (PMID:16949895) [HMDB] Ursodeoxycholic acid is produced by the action of enzymes existing in the microbial flora of the colonic environment. The major phase II metabolism of bile acids is sulfation mainly catalyzed by the hydroxysteroid sulfotransferase, forming the 3-sulfate conjugate. (PMID: 16949895).
Cortistatin A
(2R,4S)-4-Carbamimidamido-3-acetamido-2-((1R,2R)-2-hydroxy-1-methoxy-3-(octanoyloxy)propyl)-3,4-dihydro-2H-pyran-6-carboxylic acid
Methylprednisolone aceponate
3-Ketopetromyzonol sulfate
C24H40O7S (472.24946100000005)
Asn-Arg-Ala-Ile
20-O-Acetylingenol-3-angelate
13-(acetyloxy)-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl (2E)-2-methylbut-2-enoate
20-Deoxy,16-acetoxy,3-angeloyl-Ingenol|20-deoxy-16-hydroxyingenol-16-acetate-3-angelate
(+/-)-3-[(2E,6E,10E)-11-carboxy-13-hydroxy-3,7,15-trimethyl-2,6,10,14-hexadecatetraenyl]-4,5-dihydroxybenzoic acid
(1R*,2R*,5Z,10R*,11S*,12R*,14S*)-14-acetoxy-11,12-epoxy-3-oxobriara-5,7,17-trien-2-yl 3-methylbutanoate
longipin-2-ene-7beta-acetyloxy-9alpha-senecioyloxy-15-angeloyloxy-1-one
12-O-[3-methyl-2-butenoyl]-4-deoxyphorbol 13-acetate
7beta,9alpha-diangeloyloxy-8alpha-acetyloxylongipin-2-en-1-one
longipin-2-ene-7beta-acetyloxy-9alpha,15-diangeloyloxy-1-one
(+/-)-3-[(2E,6E,10E)-11-carboxy-14-hydroxy-3,7,15-trimethyl-2,6,10,15-hexadecatetraenyl]-4,5-dihydroxybenzoic acid
Val Gln Ala Arg
C27H36O7_2-Butenoic acid, 2-methyl-, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-7b-hydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester, (2E)
3Alpha-Hydroxy-3-Deoxyangolensic Acid Methyl Ester
3a-Sulfooxy-7a-OH-5b-cholanic acid
C24H40O7S (472.24946100000005)
BA-140-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-140-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-140-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-140-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
SCDCA - Sulfochenodeoxycholic acid
C24H40O7S (472.24946100000005)
13-(acetyloxy)-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl (2E)-2-methylbut-2-enoate_major
3-Deoxy-3Beta-Hydroxyangolensic Acid Methyl Ester_major
(4R)-4-((3R,5R,8R,9S,10S,12S,13R,17R)-12-hydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
C24H40O7S (472.24946100000005)
(4R)-4-((3R,5R,7R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
C24H40O7S (472.24946100000005)
13-(acetyloxy)-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,?.0¹¹,¹³]pentadeca-3,8-dien-14-yl (2E)-2-methylbut-2-enoate
Ala Ile Asn Arg
Ala Ile Arg Asn
Ala Leu Asn Arg
Ala Leu Arg Asn
Ala Asn Ile Arg
Ala Asn Leu Arg
Ala Asn Arg Ile
Ala Asn Arg Leu
Ala Gln Arg Val
Ala Gln Val Arg
Ala Arg Ile Asn
Ala Arg Leu Asn
Ala Arg Asn Ile
Ala Arg Asn Leu
Ala Arg Gln Val
Ala Arg Val Gln
Ala Val Gln Arg
Ala Val Arg Gln
Phe Ile Pro Pro
Phe Leu Pro Pro
Phe Pro Ile Pro
Phe Pro Leu Pro
Phe Pro Pro Ile
Phe Pro Pro Leu
Gly Ile Gln Arg
Gly Ile Arg Gln
Gly Leu Phe His
Gly Leu His Phe
Gly Leu Gln Arg
Gly Leu Arg Gln
Gly Gln Ile Arg
Gly Gln Leu Arg
Gly Gln Arg Ile
Gly Gln Arg Leu
Gly Arg Ile Gln
Gly Arg Leu Gln
Gly Arg Gln Ile
Gly Arg Gln Leu
His Ala Phe Val
His Ala Val Phe
His Phe Ala Val
His Phe Gly Ile
His Phe Ile Gly
His Phe Leu Gly
His Phe Val Ala
His Gly Phe Ile
His Gly Ile Phe
His Gly Leu Phe
His Ile Phe Gly
His Ile Gly Phe
His Leu Phe Gly
His Leu Gly Phe
His Val Ala Phe
His Val Phe Ala
Ile Ala Asn Arg
Ile Ala Arg Asn
Ile Phe Gly His
Ile Phe His Gly
Ile Phe Pro Pro
Ile Gly Phe His
Ile Gly His Phe
Ile Gly Gln Arg
Ile Gly Arg Gln
Ile His Phe Gly
Ile His Gly Phe
Ile Ile Met Pro
C22H40N4O5S (472.27192700000006)
Ile Ile Asn Asn
Ile Ile Pro Met
C22H40N4O5S (472.27192700000006)
Ile Leu Met Pro
C22H40N4O5S (472.27192700000006)
Ile Leu Asn Asn
Ile Leu Pro Met
C22H40N4O5S (472.27192700000006)
Ile Met Ile Pro
C22H40N4O5S (472.27192700000006)
Ile Met Leu Pro
C22H40N4O5S (472.27192700000006)
Ile Met Pro Ile
C22H40N4O5S (472.27192700000006)
Ile Met Pro Leu
C22H40N4O5S (472.27192700000006)
Ile Asn Ala Arg
Ile Asn Ile Asn
Ile Asn Leu Asn
Ile Asn Asn Ile
Ile Asn Asn Leu
Ile Asn Gln Val
Ile Asn Arg Ala
Ile Asn Val Gln
Ile Pro Phe Pro
Ile Pro Ile Met
C22H40N4O5S (472.27192700000006)
Ile Pro Leu Met
C22H40N4O5S (472.27192700000006)
Ile Pro Met Ile
C22H40N4O5S (472.27192700000006)
Ile Pro Met Leu
C22H40N4O5S (472.27192700000006)
Ile Pro Pro Phe
Ile Gln Gly Arg
Ile Gln Asn Val
Ile Gln Arg Gly
Ile Gln Val Asn
Ile Arg Ala Asn
Ile Arg Gly Gln
Ile Arg Asn Ala
Ile Arg Gln Gly
Ile Val Asn Gln
Ile Val Gln Asn
Lys Pro Gln Thr
Lys Pro Thr Gln
Lys Gln Pro Thr
Lys Gln Thr Pro
Lys Thr Pro Gln
Lys Thr Gln Pro
Leu Ala Asn Arg
Leu Ala Arg Asn
Leu Phe Gly His
Leu Phe His Gly
Leu Phe Pro Pro
Leu Gly Phe His
Leu Gly His Phe
Leu Gly Gln Arg
Leu Gly Arg Gln
Leu His Phe Gly
Leu His Gly Phe
Leu Ile Met Pro
C22H40N4O5S (472.27192700000006)
Leu Ile Asn Asn
Leu Ile Pro Met
C22H40N4O5S (472.27192700000006)
Leu Leu Met Pro
C22H40N4O5S (472.27192700000006)
Leu Leu Asn Asn
Leu Leu Pro Met
C22H40N4O5S (472.27192700000006)
Leu Met Ile Pro
C22H40N4O5S (472.27192700000006)
Leu Met Leu Pro
C22H40N4O5S (472.27192700000006)
Leu Met Pro Ile
C22H40N4O5S (472.27192700000006)
Leu Met Pro Leu
C22H40N4O5S (472.27192700000006)
Leu Asn Ala Arg
Leu Asn Ile Asn
Leu Asn Leu Asn
Leu Asn Asn Ile
Leu Asn Asn Leu
Leu Asn Gln Val
Leu Asn Arg Ala
Leu Asn Val Gln
Leu Pro Phe Pro
Leu Pro Ile Met
C22H40N4O5S (472.27192700000006)
Leu Pro Leu Met
C22H40N4O5S (472.27192700000006)
Leu Pro Met Ile
C22H40N4O5S (472.27192700000006)
Leu Pro Met Leu
C22H40N4O5S (472.27192700000006)
Leu Pro Pro Phe
Leu Gln Gly Arg
Leu Gln Asn Val
Leu Gln Arg Gly
Leu Gln Val Asn
Leu Arg Ala Asn
Leu Arg Gly Gln
Leu Arg Asn Ala
Leu Arg Gln Gly
Leu Val Asn Gln
Leu Val Gln Asn
Met Ile Ile Pro
C22H40N4O5S (472.27192700000006)
Met Ile Leu Pro
C22H40N4O5S (472.27192700000006)
Met Ile Pro Ile
C22H40N4O5S (472.27192700000006)
Met Ile Pro Leu
C22H40N4O5S (472.27192700000006)
Met Leu Ile Pro
C22H40N4O5S (472.27192700000006)
Met Leu Leu Pro
C22H40N4O5S (472.27192700000006)
Met Leu Pro Ile
C22H40N4O5S (472.27192700000006)
Met Leu Pro Leu
C22H40N4O5S (472.27192700000006)
Met Pro Ile Ile
C22H40N4O5S (472.27192700000006)
Met Pro Ile Leu
C22H40N4O5S (472.27192700000006)
Met Pro Leu Ile
C22H40N4O5S (472.27192700000006)
Met Pro Leu Leu
C22H40N4O5S (472.27192700000006)
Asn Ala Ile Arg
Asn Ala Leu Arg
Asn Ala Arg Ile
Asn Ala Arg Leu
Asn Ile Ala Arg
Asn Ile Ile Asn
Asn Ile Leu Asn
Asn Ile Asn Ile
Asn Ile Asn Leu
Asn Ile Gln Val
Asn Ile Arg Ala
Asn Ile Val Gln
Asn Leu Ala Arg
Asn Leu Ile Asn
Asn Leu Leu Asn
Asn Leu Asn Ile
Asn Leu Asn Leu
Asn Leu Gln Val
Asn Leu Arg Ala
Asn Leu Val Gln
Asn Asn Ile Ile
Asn Asn Ile Leu
Asn Asn Leu Ile
Asn Asn Leu Leu
Asn Gln Ile Val
Asn Gln Leu Val
Asn Gln Val Ile
Asn Gln Val Leu
Asn Arg Ala Ile
Asn Arg Ala Leu
Asn Arg Ile Ala
Asn Arg Leu Ala
Asn Val Ile Gln
Asn Val Leu Gln
Asn Val Gln Ile
Asn Val Gln Leu
Pro Phe Ile Pro
Pro Phe Leu Pro
Pro Phe Pro Ile
Pro Phe Pro Leu
Pro Ile Phe Pro
Pro Ile Ile Met
C22H40N4O5S (472.27192700000006)
Pro Ile Leu Met
C22H40N4O5S (472.27192700000006)
Pro Ile Met Ile
C22H40N4O5S (472.27192700000006)
Pro Ile Met Leu
C22H40N4O5S (472.27192700000006)
Pro Ile Pro Phe
Pro Lys Gln Thr
Pro Lys Thr Gln
Pro Leu Phe Pro
Pro Leu Ile Met
C22H40N4O5S (472.27192700000006)
Pro Leu Leu Met
C22H40N4O5S (472.27192700000006)
Pro Leu Met Ile
C22H40N4O5S (472.27192700000006)
Pro Leu Met Leu
C22H40N4O5S (472.27192700000006)
Pro Leu Pro Phe
Pro Met Ile Ile
C22H40N4O5S (472.27192700000006)
Pro Met Ile Leu
C22H40N4O5S (472.27192700000006)
Pro Met Leu Ile
C22H40N4O5S (472.27192700000006)
Pro Met Leu Leu
C22H40N4O5S (472.27192700000006)
Pro Pro Phe Ile
Pro Pro Phe Leu
Pro Pro Ile Phe
Pro Pro Leu Phe
Pro Gln Lys Thr
Pro Gln Thr Lys
Pro Thr Lys Gln
Pro Thr Gln Lys
Gln Ala Arg Val
Gln Ala Val Arg
Gln Gly Ile Arg
Gln Gly Leu Arg
Gln Gly Arg Ile
Gln Gly Arg Leu
Gln Ile Gly Arg
Gln Ile Asn Val
Gln Ile Arg Gly
Gln Ile Val Asn
Gln Lys Pro Thr
Gln Lys Thr Pro
Gln Leu Gly Arg
Gln Leu Asn Val
Gln Leu Arg Gly
Gln Leu Val Asn
Gln Asn Ile Val
Gln Asn Leu Val
Gln Asn Val Ile
Gln Asn Val Leu
Gln Pro Lys Thr
Gln Pro Thr Lys
Gln Gln Val Val
Gln Arg Ala Val
Gln Arg Gly Ile
Gln Arg Gly Leu
Gln Arg Ile Gly
Gln Arg Leu Gly
Gln Arg Val Ala
Gln Thr Lys Pro
Gln Thr Pro Lys
Gln Val Ala Arg
Gln Val Ile Asn
Gln Val Leu Asn
Gln Val Asn Ile
Gln Val Asn Leu
Gln Val Gln Val
Gln Val Arg Ala
Gln Val Val Gln
Arg Ala Ile Asn
Arg Ala Leu Asn
Arg Ala Asn Ile
Arg Ala Asn Leu
Arg Ala Gln Val
Arg Ala Val Gln
Arg Gly Ile Gln
Arg Gly Leu Gln
Arg Gly Gln Ile
Arg Gly Gln Leu
Arg Ile Ala Asn
Arg Ile Gly Gln
Arg Ile Asn Ala
Arg Ile Gln Gly
Arg Leu Ala Asn
Arg Leu Gly Gln
Arg Leu Asn Ala
Arg Leu Gln Gly
Arg Asn Ala Ile
Arg Asn Ala Leu
Arg Asn Ile Ala
Arg Asn Leu Ala
Arg Gln Ala Val
Arg Gln Gly Ile
Arg Gln Gly Leu
Arg Gln Ile Gly
Arg Gln Leu Gly
Arg Gln Val Ala
Arg Val Ala Gln
Arg Val Gln Ala
Thr Lys Pro Gln
Thr Lys Gln Pro
Thr Pro Lys Gln
Thr Pro Gln Lys
Thr Gln Lys Pro
Thr Gln Pro Lys
Val Ala Phe His
Val Ala Gln Arg
Val Ala Arg Gln
Val Ile Asn Gln
Val Ile Gln Asn
Val Leu Asn Gln
Val Leu Gln Asn
Val Asn Ile Gln
Val Asn Leu Gln
Val Asn Gln Ile
Val Asn Gln Leu
Val Gln Ile Asn
Val Gln Leu Asn
Val Gln Asn Ile
Val Gln Asn Leu
Val Gln Gln Val
Val Gln Arg Ala
Val Gln Val Gln
Val Arg Ala Gln
Val Arg Gln Ala
Val Val Gln Gln
Ursodeoxycholate 3-sulfate
C24H40O7S (472.24946100000005)
Lucidenic acid K
9a-Acetoxy-7b-hydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-1H-cyclopropa[3,4]benzo[1,2-e]azulen-9-yl (2E)-2-methyl-2-butenoate
LPA 21:4
C24H41O7P (472.25897660000004)
ST 24:1;O4;S
C24H40O7S (472.24946100000005)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Sulukast
C25H36N4O3S (472.25079860000005)
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent
Pacritinib
C28H32N4O3 (472.24742819999994)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EJ - Janus-associated kinase (jak) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Methylprednisolone aceponate
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents
Cortistatin A
A member of the class of cortistatins that is substituted by hydroxy groups at positions 1 and 2, a dimethylamino group at the 3alpha position and an isoquinolin-7-yl group at the 17 position, with double bonds at the 9-11 and 10-19 positions (the 1R,2R,17beta enantiomer).
7-(3,4-dimethoxyphenyl)-4-methyl-2-[4-(phenylmethyl)-1-piperazinyl]-7,8-dihydro-6H-quinazolin-5-one
C28H32N4O3 (472.24742819999994)
(2R,4S)-4-Carbamimidamido-3-acetamido-2-((1R,2R)-2-hydroxy-1-methoxy-3-(octanoyloxy)propyl)-3,4-dihydro-2H-pyran-6-carboxylic acid
[(2R,3R,4S,5S)-2-[(1S,2S,3R,4S,6R)-4,6-bis(azaniumyl)-3-[(2S,3R,4R,5S,6R)-3-azaniumyl-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3,5-dihydroxyoxan-4-yl]-methylazanium
C18H40N4O10+4 (472.27443000000005)
3alpha-Sulfooxy-12alpha-hydroxy-5beta-cholan-24-oic acid
C24H40O7S (472.24946100000005)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
[13-acetyloxy-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] (E)-2-methylbut-2-enoate
Homoplatensimide A Methyl Ester
A carboxylic ester of homoplatensimide A isolated from Streptomyces platensis.
(3R,4R)-N-[3-(dimethylamino)propyl]-3-[4-(hydroxymethyl)phenyl]-2-(5-methyl-2-pyridinyl)-1-oxo-3,4-dihydroisoquinoline-4-carboxamide
C28H32N4O3 (472.24742819999994)
[(1R)-7-methoxy-9-methyl-1-[(5-phenyl-3-isoxazolyl)methyl]-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C28H32N4O3 (472.24742819999994)
1-[[(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(2S,3S)-8-(2-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3R)-8-(2-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3S)-8-(2-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3S)-8-(2-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-(3-fluorophenyl)-3-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(10R,11S)-10-[[benzyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
[(1S)-7-methoxy-9-methyl-1-[(5-phenyl-3-isoxazolyl)methyl]-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C28H32N4O3 (472.24742819999994)
1-[[(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(2S,3S)-8-(2-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3R)-8-(2-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3R)-8-(2-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3R)-8-(2-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-(3-fluorophenyl)-3-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5R,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(10S,11S)-10-[[benzyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
(10R,11S)-10-[[benzyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
(10S,11R)-10-[[benzyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
methyl 2-[(1S,3S,5R,7S,8S,9S,12S,13S)-13-(furan-3-yl)-5-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]acetate
Laninamivir octanoate
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents
Chenodeoxycholic acid 3-sulfate
C24H40O7S (472.24946100000005)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
LPMe(20:4)
C24H41O7P (472.25897660000004)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved